Treatment of Clinical Mastitis

Roberson, Jerry R.

doi:10.1016/j.cvfa.2012.03.011

Cited by 63 publications

(69 citation statements)

References 39 publications

(49 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The most susceptible animals can yet develop infectious diseases such as mastitis and metritis [5,6]. Bacteria are among the main causative agents of bovine mastitis; however, fungi, yeasts, viruses, and algae have also been associated with this disease [7,8].…”

Section: Introductionmentioning

confidence: 99%

In vitro photoinactivation of bovine mastitis related pathogens

Sellera

Sabino

Ribeiro

et al. 2016

Photodiagnosis and Photodynamic Therapy

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

In vitro photoinactivation of bovine mastitis related pathogens

Sellera

Sabino

Ribeiro

et al. 2016

Photodiagnosis and Photodynamic Therapy

View full text Add to dashboard Cite

“…To control the incidence of mastitis, it is necessary to be aware of the causative agents of inflammation of the udder, and particularly to follow up on new knowledge regarding the etiology, prevalence, and clinical course of the disease, the economic aspects of its prevention and control, and new approaches to the prevention and treatment of udder inflammation (Oliver et al, 2004;Roberson, 2012).…”

Section: Treatment Of Mastitis With Ozonementioning

confidence: 99%

Prophylaxis and therapeutic potential of ozone in buiatrics: Current knowledge

Đuričić

Valpotić

Samardžija

2015

Animal Reproduction Science

View full text Add to dashboard Cite

“…In addition, cows with coliform CM receiving intramuscular ceftiofur had lower risk of death or culling (13.8%) in comparison to cows that were not treated with the systematically administered antimicrobial (37%; Erskine et al, 2002). However, for treatment of mild and moderate CM, the administration of systemic antimicrobials is controversial and not usually necessary (ROBERSON, 2012). In our study, the use of systematically administered antimicrobials was reported for 65.2% of cows that had mild or moderate CM.…”

Section: Antimicrobial Treatment Incidencementioning

confidence: 83%

“…Although management practices such as the use of adequate milking procedures, provide good nutrition, and the maintenance of the cows' comfort and hygiene, can assist in the control and prevention of IMI, these factors have little effect on eliminating intercurrent cases of CM (HOGAN, JOE;SMITH, 2012;ROBERSON, 2012). Therefore, the use of antimicrobials remains the most effective strategy for treatment of CM in dairy cows.…”

Section: List Of Figuresmentioning

confidence: 99%

“…to one or both of these antimicrobials (ROSSITTO et al, 2002;RAJALA-SCHULTZ et al, 2004;KACZOREK et al, 2017). Both tetracycline and sulfadimethoxine are antimicrobials that are frequently used to treat respiratory and other diseases in cattle by the systemic route, and neither of these two agents are recommended for treatment of CM, especially those without systemic signs (ROSSITTO et al, 2002;ROBERSON, 2012).…”

Section: Streptococcus Uberismentioning

confidence: 99%

See 1 more Smart Citation

<b>Etiological and molecular profile of pathogens causing clinical mastitis, and antimicrobial use in dairy herds</b>

Tomazi¹

View full text Add to dashboard Cite

Pirassununga 2017Autorizo a reprodução parcial ou total desta obra, para fins acadêmicos, desde que citada a fonte. DADOS INTERNACIONAIS DE CATALOGAÇÃO NA PUBLICAÇÃO(Biblioteca Virginie Buff D'Ápice da Faculdade de Medicina Veterinária e Zootecnia da Universidade de São Paulo) T. 3560 Tomazi, Tiago FMVZ Etiological and molecular profile of pathogens causing clinical mastitis, and antimicrobial use in dairy herds. / Tiago Tomazi. --2017. 187 f. : il.Título traduzido: Perfil etiológico e molecular de patógenos causadores de mastite clínica, e uso de antimicrobianos em rebanhos leiteiros. AGRADECIMENTOS (ACKNOWLEDGEMENTS)Primeiramente agradeço a Deus pelas oportunidades que me tens dado de testemunhar o amor que tens por mim. Agradeço também ao Senhor pelos animais, seres divinos e frutos do meu trabalho. É em suas mãos que entrego as rédeas da minha vida.Agradeço também à Nossa Senhora de Lourdes por iluminar o meu caminho e a minha família. E por sempre atender aos meus pedidos.A minha família por jamais deixar faltar confiança, apoio, carinho, compreensão e amor.E por provar que um coração pode se sentir aquecido e amado, mesmo a quilômetros de distância. Muito obrigado a minha mãe, pai e irmãos Lucas e Lutiene.Aos meus avós Alcides, Elvira, Alberto e Antonieta por me ensinar o "respeito", uma das virtudes mais belas de um ser humano.A minha namorada, noiva e confidente Ana Carolina de Campos Henrique, que tem um coração enormemente capaz de suportar meu amor e todos os outros sentimentos às vezes não tão prazerosos. Meus momentos felizes ficam ainda mais felizes ao seu lado; e meus momentos de tristeza e fraqueza logo se desfazem na presença de sua palavra e companhia. quarter-cases of CM were recorded and the most frequently isolated pathogens were Escherichia coli (6.6% of total cultures), Streptococcus uberis (6.1%), and Streptococcus agalactiae (5.9%). The majority of CM cases were mild (60.3%), while 34.1% were moderate and 5.6% severe. Overall, the IRCM was 9.7 quarter-cases per 10,000 quarter-days at risk (QDAR), and the only herd-level parameter associated with overall IRCM was BMSCC, in which the highest IRCM was observed for herds with BMSCC >600.000 × 10 3 cells/mL. In the models evaluating the specific-pathogen groups, IRCM with isolation of major contagious pathogens was associated with BMSCC, milk yield and housing system. For the evaluation of other Gram-positive pathogens, the IRCM was higher in the rainy season of 2015 in comparison with the other seasonal categories. In addition, for the model evaluating the Gram-negative group, the IRCM was highest in herds with BMTBC >30 × 10 3 cfu/mL. The Study 2 aimed to characterize the treatment profile and quantify the antimicrobial consumption for treatment of CM in dairy herds; and to determine the association of antimicrobial use (AMU) and the same herd-level descriptors as described in the Study 1. Data on treatment practices and AMU were obtained from 19 dairy herds for a period of 12 months per herd. The AMU for treatment of CM was quantifie...

show abstract

Treatment of Clinical Mastitis

Cited by 63 publications

References 39 publications

In vitro photoinactivation of bovine mastitis related pathogens

In vitro photoinactivation of bovine mastitis related pathogens

Prophylaxis and therapeutic potential of ozone in buiatrics: Current knowledge

<b>Etiological and molecular profile of pathogens causing clinical mastitis, and antimicrobial use in dairy herds</b>

Contact Info

Product

Resources

About